RecruitingPhase 1NCT06502834

Effect of 4 Weeks of Oral D. Piger on Safety, Pharmacokinetics and Ethanol Metabolism in Overweight Individuals (2023)


Sponsor

Max Nieuwdorp

Enrollment

20 participants

Start Date

May 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of the study is to determine the effect of supplementation of the d piger strain on intestinal ethanol production in individuals with overweight. The investigators will perform a randomized trial in 2x10 participants to measure effects on ethanol in blood, and perform fecal analyses.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Inclusion Criteria4

  • Male or (postmenopausal) females
  • Increased waist circumference (>102 cm men, 88>cm women)
  • Insulin resistance (HOMA>2.5)
  • -70 years

Exclusion Criteria7

  • Use of systemic medication (except for paracetamol), including antibiotics and pro-/prebiotics in the past three months or during the study period.
  • A history of a cardiovascular event
  • A history of cholecystectomy
  • Overt untreated gastrointestinal disease or abnormal bowel habits
  • Liver enzymes>2.5 fold higher than the upper limit of normal range
  • Smoking
  • Alcohol abuse

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTD piger

Probiotic d piger

DIETARY_SUPPLEMENTPlacebo

Placebo


Locations(1)

Amsterdam UMC location AMC

Amsterdam, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06502834


Related Trials